King's College London

Researchers

• SBStergios Boussios

Running trials

• Not yet recruiting

  Stratification and Treatment in Early Psychosis Study - PROMOTE

  NCT07434973· Phase 3· University of Oxford· Source

• Not yet recruiting

  An Investigation of Mechanisms That Underly Paranoia in Behaviour and Brain That Can Inform Clinical Diagnoses That Include Paranoid Symptoms.

  NCT07878130· Phase 2· King's College London· Source

• Recruiting

  Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction

  NCT07403058· Axon Therapies, Inc.· Source

• Not yet recruiting

  Local Field Potential Correlates of Neuropsychiatric Symptoms in Parkinson's Disease

  NCT07633379· King's College London· Source

• Not yet recruiting

  An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function

  NCT07613398· Matthias Stuber· Source

• Active, not recruiting

  The Effect of Continuous Positive Airway Therapy on the Blood Pressure in Sleepy vs Non-sleepy Patients With Obstructive Sleep Apnea

  NCT07497412· King's College London· Source

• Recruiting

  A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  NCT06793397· Phase 3· Cybin IRL Limited· Source

• Enrolling by invitation

  Supporting Sexual Recovery in Women With Bladder Cancer

  NCT07091565· King's College London· Source

• Active, not recruiting

  Improving Cognitive Recovery in Multiple Sclerosis

  NCT06877273· King's College London· Source

• Recruiting

  The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

  NCT05973786· Phase 3· Dr. Inge Winter· Source

• Recruiting

  Comorbid Obesity and Depression With an Anti-inflammatory Medication

  NCT06537921· King's College London· Source

• Recruiting

  The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

  NCT05973851· Phase 3· Dr. Inge Winter· Source

• Recruiting

  The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

  NCT05958875· Phase 4· Dr. Inge Winter· Source

• Recruiting

  Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk

  NCT06224530· King's College London· Source

• Active, not recruiting

  Balance Acceptance and Commitment Therapy for Long COVID

  NCT06231238· King's College London· Source

• Recruiting

  Social Isolation and Aging in Schizophrenia

  NCT07419321· Icahn School of Medicine at Mount Sinai· Source

• Active, not recruiting

  Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

  NCT05711940· Phase 3· COMPASS Pathways· Source

• Enrolling by invitation

  UK Based Remote Brain Health Clinic (BHC) for Patients With Mild Cognitive Impairment (MCI)

  NCT06379594· South London and Maudsley NHS Foundation Trust· Source

• Active, not recruiting

  AMP SCZ® Observational Study: PREDICT-DPACC

  NCT05905003· Brigham and Women's Hospital· Source

• Recruiting

  E-Detection Tool for Emerging Mental Disorders

  NCT05127278· King's College London· Source

• Recruiting

  IMarkHD: in Vivo Longitudinal Imaging of HD Pathology

  NCT03434548· King's College London· Source

• Recruiting

  International Validation of Two Non-motor Scales in PD (NFS and SPARK)

  NCT04366804· Insel Gruppe AG, University Hospital Bern· Source

• Recruiting

  Personalized Responses to Dietary Composition Trial 3

  NCT04735835· Zoe Global Limited· Source

• Active, not recruiting

  EPA for Metastasis Trial 2

  NCT03428477· Phase 3· Mark A Hull, PhD FRCP· Source

• Recruiting

  A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.

  NCT03320304· LivaNova· Source

• Recruiting

  EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)

  NCT03369821· University of Exeter· Source

• Recruiting

  Brain Imaging in Babies Study

  NCT04443179· King's College London· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression5 recruiting
• Schizophrenia5 recruiting
• Obesity2 recruiting
• Parkinson disease2 recruiting
• Alzheimer disease1 recruiting
• Autism1 recruiting
• Bipolar disorder1 recruiting
• Bladder cancer1 recruiting
• Congenital heart disease1 recruiting
• Heart failure1 recruiting
• Huntington's disease1 recruiting

Closed trials

• Completed

  Entropy-based Physiological Signal Analysis in Patients With Obstructive Sleep Apnoea

  NCT07406620· King's College London· Source

• Completed

  Test-retest Study With [18F]FBB in Cardiac Amyloidosis

  NCT06790394· Phase 1· Lantheus Germany GmbH· Source

• Completed

  Developing a Novel Therapy for Aversive Sensory Experiences in Autism

  NCT06682858· King's College London· Source

• Completed

  Cognitive Remediation for Autistic Adolescents

  NCT06989151· Early phase 1· South London and Maudsley NHS Foundation Trust· Source

• Completed

  MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY)

  NCT06308549· Maartje de Wit· Source

• Completed

  Extension Study Evaluating The Safety And Tolerability of AMX0035

  NCT05619783· Phase 3· Amylyx Pharmaceuticals Inc.· Source

• Completed

  Psilocybin in Adults With and Without Autism Spectrum Disorder

  NCT05651126· King's College London· Source

• Completed

  Service User and Staff Views on Digital Remote Monitoring for Psychosis

  NCT05670197· Manchester Academic Health Science Centre· Source

• Completed

  Molehill Mountain Feasibility Study.

  NCT05302167· King's College London· Source

• Completed

  Asking People With Psoriasis About Lifestyle and Eating

  NCT05448352· King's College London· Source

• Completed

  Elucidating Age-related Comorbidity Patterns in Down Syndrome (DS)

  NCT05310552· King's College London· Source

• Completed

  Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder

  NCT04745026· Phase 2· Jazz Pharmaceuticals· Source

• Completed

  Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders

  NCT05171725· Neurological Institute of Athens· Source

• Completed

  GABA Pathways in Autism Spectrum Disorder (ASD)

  NCT03678129· King's College London· Source

• Completed

  Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

  NCT02731612· Phase 3· Lakshmi N Yatham· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Schizophrenia301 works · 7 trials
• Obesity245 works · 3 trials
• Alzheimer disease238 works · 2 trials
• Stroke225 works · 0 trials
• Type 2 diabetes184 works · 0 trials
• Heart failure178 works · 1 trial
• Depression157 works · 6 trials
• Asthma150 works · 0 trials
• Bipolar disorder123 works · 2 trials
• Parkinson disease101 works · 2 trials
• Atrial fibrillation99 works · 0 trials
• Psoriasis98 works · 1 trial
• Chronic kidney disease97 works · 0 trials
• Epilepsy93 works · 1 trial
• Migraine86 works · 0 trials
• Rheumatoid arthritis86 works · 0 trials
• Type 1 diabetes78 works · 2 trials
• HIV78 works · 0 trials
• ALS (motor neurone disease)77 works · 1 trial
• Autism76 works · 7 trials
• Coronary artery disease76 works · 0 trials
• Melanoma68 works · 0 trials
• Atopic dermatitis (eczema)68 works · 0 trials
• COPD66 works · 0 trials
• Prostate cancer50 works · 0 trials
• Insomnia49 works · 0 trials
• Fatty liver disease (MASLD/MASH)48 works · 0 trials
• Multiple sclerosis44 works · 1 trial
• Lupus (SLE)42 works · 0 trials
• Osteoarthritis41 works · 0 trials